Effects of Simvastatin Versus Simvastatin Combined With Ezetimibe on Blood Coagulation in Patients With Acute Coronary Events: Relationship With Cholesterol-Lowering and Anti-Inflammatory Properties
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Ezetimibe; Simvastatin
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- 11 Dec 2009 Trial sponsor changed from Merck Sharp & Dohme to Merck and Co as reported by ClinicalTrials.gov.
- 09 Feb 2009 Planned end date changed from 1 Mar 2009 to 1 Dec 2009 as reported by ClinicalTrials.gov.
- 27 Aug 2008 New trial record.